Germline Genetic Association Between Stromal Interaction Molecule 1 (STIM1) and Clinical Outcomes in Breast Cancer Patients

Overview

Journal J Pers Med

Date 2020 Dec 22

PMID 33348924

Citations 1

Authors

Chi-Cheng Huang

Min-Rou Lin

Yu-Chen Yang

Yu-Wen Hsu

Henry Sung-Ching Wong

Wei-Chiao Chang

Affiliations

Soon will be listed here.

Abstract

Among all cancers in women, breast cancer has the highest incidence. The mortality of breast cancer is highly associated with metastasis. Migration and malignant transformation of cancer cells have been reported to be modulated by store-operated calcium (SOC) channels, which control calcium signaling and cell proliferation pathways. Stromal interaction molecule 1 ( is a calcium sensor in the endoplasmic reticulum, triggering the activation of store-operated calcium signaling. However, the clinical relevance of in breast cancer is still unclear. Here, we recruited 348 breast cancer patients and conducted a genetic association study to address this question. Four tagging germline single nucleotide variants (SNVs) in were selected and RNA sequencing data of 525 breast cancer samples from The Cancer Genome Atlas (TCGA) database were evaluated. The results show that rs2304891 and rs3750996 were correlated with clinical stage of breast cancer. Expression quantitative trait loci (eQTL) analysis indicated that risk G allele of contributed to the higher expression of . In addition, we found an increased risk of rs2304891 G allele and rs3750996 A allele in estrogen receptor (ER) positive and progesterone receptor (PR) positive patients. In conclusion, our results suggest that germline SNV, rs2304891 and rs3750996 as well as expression are important biomarkers for the prediction of clinical outcomes in breast cancer patients.

Citing Articles

Molecular Pathology of Cancer: The Past, the Present, and the Future.

Mullauer L J Pers Med. 2021; 11(7).

PMID: 34357143 PMC: 8305942. DOI: 10.3390/jpm11070676.

References

Yang S, Zhang J, Huang X . Orai1 and STIM1 are critical for breast tumor cell migration and metastasis. Cancer Cell. 2009; 15(2):124-34. DOI: 10.1016/j.ccr.2008.12.019. View

Wang J, Chen B, Wang Y, Tsai Y, Chen W, Chang W . Involvement of store-operated calcium signaling in EGF-mediated COX-2 gene activation in cancer cells. Cell Signal. 2011; 24(1):162-9. DOI: 10.1016/j.cellsig.2011.08.017. View

Huang W, Chai C, Chen W, Hou M, Wang Y, Chiu Y . Histamine regulates cyclooxygenase 2 gene activation through Orai1-mediated NFκB activation in lung cancer cells. Cell Calcium. 2011; 50(1):27-35. DOI: 10.1016/j.ceca.2011.04.004. View

Yang Y, Jiang Z, Ma N, Wang B, Liu J, Zhang L . MicroRNA-223 Targeting STIM1 Inhibits the Biological Behavior of Breast Cancer. Cell Physiol Biochem. 2018; 45(2):856-866. DOI: 10.1159/000487180. View

Kuo C, Liao Y, Kuo L, Tsai H, Chang W, Yen Y . Cancers in Taiwan: Practical insight from epidemiology, treatments, biomarkers, and cost. J Formos Med Assoc. 2019; 119(12):1731-1741. DOI: 10.1016/j.jfma.2019.08.023. View

Thiha K, Mashimo Y, Suzuki H, Hamada H, Hata A, Hara T . Investigation of novel variations of ORAI1 gene and their association with Kawasaki disease. J Hum Genet. 2019; 64(6):511-519. DOI: 10.1038/s10038-019-0588-2. View

Baumgarten S, Frasor J . Minireview: Inflammation: an instigator of more aggressive estrogen receptor (ER) positive breast cancers. Mol Endocrinol. 2012; 26(3):360-71. PMC: 3286192. DOI: 10.1210/me.2011-1302. View

Ray K . Calcium-Sensing Receptor: Trafficking, Endocytosis, Recycling, and Importance of Interacting Proteins. Prog Mol Biol Transl Sci. 2015; 132:127-50. DOI: 10.1016/bs.pmbts.2015.02.006. View

Wang J, Sun J, Huang M, Wang Y, Hou M, Sun Y . STIM1 overexpression promotes colorectal cancer progression, cell motility and COX-2 expression. Oncogene. 2014; 34(33):4358-67. PMC: 4426254. DOI: 10.1038/onc.2014.366. View

10.

Parekh A, Putney Jr J . Store-operated calcium channels. Physiol Rev. 2005; 85(2):757-810. DOI: 10.1152/physrev.00057.2003. View

11.

Ghoncheh M, Pournamdar Z, Salehiniya H . Incidence and Mortality and Epidemiology of Breast Cancer in the World. Asian Pac J Cancer Prev. 2016; 17(S3):43-6. DOI: 10.7314/apjcp.2016.17.s3.43. View

12.

Ho K, Chang C, Chen P, Wang Y, Chang W, Chen K . miR-4725-3p targeting stromal interacting molecule 1 signaling is involved in xanthohumol inhibition of glioma cell invasion. J Neurochem. 2018; 146(3):269-288. DOI: 10.1111/jnc.14459. View

13.

Miller K, Siegel R, Lin C, Mariotto A, Kramer J, Rowland J . Cancer treatment and survivorship statistics, 2016. CA Cancer J Clin. 2016; 66(4):271-89. DOI: 10.3322/caac.21349. View

14.

Goetz M, Gradishar W, Anderson B, Abraham J, Aft R, Allison K . NCCN Guidelines Insights: Breast Cancer, Version 3.2018. J Natl Compr Canc Netw. 2019; 17(2):118-126. DOI: 10.6004/jnccn.2019.0009. View

15.

Hanahan D, Weinberg R . Hallmarks of cancer: the next generation. Cell. 2011; 144(5):646-74. DOI: 10.1016/j.cell.2011.02.013. View

16.

Kozomara A, Griffiths-Jones S . miRBase: annotating high confidence microRNAs using deep sequencing data. Nucleic Acids Res. 2013; 42(Database issue):D68-73. PMC: 3965103. DOI: 10.1093/nar/gkt1181. View

17.

Anderson K, Schwab R, Martinez M . Reproductive risk factors and breast cancer subtypes: a review of the literature. Breast Cancer Res Treat. 2014; 144(1):1-10. PMC: 4026199. DOI: 10.1007/s10549-014-2852-7. View

18.

Clarke R, Leonessa F, Welch J, Skaar T . Cellular and molecular pharmacology of antiestrogen action and resistance. Pharmacol Rev. 2001; 53(1):25-71. View

19.

Slade D . PARP and PARG inhibitors in cancer treatment. Genes Dev. 2020; 34(5-6):360-394. PMC: 7050487. DOI: 10.1101/gad.334516.119. View

20.

Abbate A, Trankle C, Buckley L, Lipinski M, Appleton D, Kadariya D . Interleukin-1 Blockade Inhibits the Acute Inflammatory Response in Patients With ST-Segment-Elevation Myocardial Infarction. J Am Heart Assoc. 2020; 9(5):e014941. PMC: 7335541. DOI: 10.1161/JAHA.119.014941. View